Search Results - "Burminskiy, Denis S."
-
1
Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia
Published in Neuropsychobiology (01-04-2022)“…The pathophysiological mechanisms of acute schizophrenia are largely unknown, but it is widely accepted that dopamine D2 receptors (DRD2s) are involved in…”
Get more information
Journal Article -
2
Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study
Published in Journal of psychiatric research (01-11-2021)“…Generalized anxiety disorder (GAD) is associated with an imbalance in the functioning of the stimulating neurotransmitter systems in human's brain. We studied…”
Get full text
Journal Article -
3
Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study
Published in CNS spectrums (01-08-2014)“…The serotoninergic system as a target for add-on treatment seems to be a promising approach in patients with schizophrenia…”
Get full text
Journal Article -
4
Using Virtual Reality for Relaxation in Patients with Schizophrenia. A Pilot Study
Published in Nat͡s︡ionalʹnyĭ psikhologicheskiĭ zhurnal (01-12-2023)“…Background. The article discusses the possibilities and prospects of using virtual reality (VR) technology as a method of relaxation in schizophrenic patients…”
Get full text
Journal Article -
5
Guideline for the use of therapeutic drug monitoring of antipsychotics to individualize the selection of therapy in the treatment of exacerbation of schizophrenia
Published in Obozrenie psikhiatrii i medit︠s︡inskoĭ psikhologii imeni V.M. Bekhtereva (02-11-2023)“…Significant individual variability in the concentration of antipsychotics (AP) and its impact on both the efficacy and safety of therapy has been shown in many…”
Get full text
Journal Article